Nasdaq IPOs

Yalla Group, which provides a voice-centric social networking and entertainment platform in MENA, raised $140 million by offering 18.6 million ADSs at $7.50, within the range of $7 to $9. Insider Orchid Asia had indicated on $30 million worth of ADSs in the offering. At pricing,

Pulmonx, which makes minimally invasive systems to treat severe emphysema, raised the proposed deal size for its upcoming IPO on Wednesday. The Redwood City, CA-based company now plans to raise $175 million by offering 10 million shares at a price range of $17 to $18. The company

Chindata Group Holdings, an integrated data center operator focusing on Asia-Pacific emerging markets, raised $540 million by offering 40 million ADSs at $13.50, the high end of the range of $11.50 to $13.50. Chindata Group Holdings plans to list on the Nasdaq under the symbol CD

Aziyo Biologics, which makes regenerative medical products for various tissue types, announced terms for its IPO on Wednesday. The Silver Spring, MD-based company plans to raise $50 million by offering 2.9 million shares at a price range of $16 to $18. Insiders intend to purchase

Boqii Holding, China's largest pet-focused online retailer, raised $70 million by offering 7 million ADSs at $10, the low end of the range of $10 to $12. At pricing, the company raised 9% less in proceeds than anticipated. Boqii Holding plans to list on the NYSE under the symbol

Qell Acquisition, a blank check company formed by PIMCO and industry veterans targeting a sustainable tech business, raised $330 million by offering 33 million units at $10. The company offered 3 million more units than anticipated. Each unit consists of one share of common stock

FG New America Acquisition, a blank check company led by TD Ameritrade Chairman Joseph Moglia targeting insurtech and fintech businesses, raised $225 million by offering 22.5 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exe

Asana's reference price is set at $21.00 ahead of its direct listing on Wednesday, according to the New York Stock Exchange. At that price, the work collaboration unicorn would command a fully diluted market value of $3.9 billion.For IPO news alerts and enhanced stories and

Palantir Technologies' reference price is set at $7.25 ahead of its direct listing on Wednesday, according to the New York Stock Exchange. At that price, Palantir would command a fully diluted market value of more than $15 billion, and would be the year's sixth-largest US listin

Northern Star Acquisition, a blank check company formed by Joanna Coles and SPAC veteran Jonathan Ledecky targeting consumer-focused businesses, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans

Climate Change Crisis Real Impact I Acquisition, a blank check company formed by PIMCO and industry veterans targeting climate change-fighting sectors, raised $200 million by offering 20 million units at $10. To screen for upcoming or past SPAC IPOs, sign up for a free trial of I

Vesper Healthcare Acquisition, a blank check company formed by the former CEO of Allergan targeting the healthcare sector, raised $400 million by offering 40 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50.&n

SCP & CO Healthcare Acquisition, a blank check company formed by SCP & CO targeting the healthcare industry, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. The Tampa, FL-based company plans to raise $200 million by offering 20 mil

Datto Holding, which sells a hybrid IT infrastructure platform to managed service providers, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $400 million.

Horizon Acquisition II, the second blank check company formed by Todd Boehly of Eldridge Industries targeting the media and entertainment industries, filed on Tuesday with the SEC to raise up to $500 million in an initial public offering. The Greenwich, CT-based company plans to

PaxMedica, a Phase 2 biotech developing therapies for neurodevelopmental disorders, revised the terms of its upcoming IPO on Tuesday. The Woodcliff Lake, NJ-based company now plans to raise $15 million by offering 2.6 million shares at a price range of $5.50 to $6.50. The company

Orphazyme, a Danish late-stage biotech developing protein therapies for rare neurodegenerative diseases, raised $84 million by offering 7.6 million ADS equivalents at $11, below the as-converted last close of its shares on the Nasdaq Copenhagen (ORPHA). At pricing, the company ra

Spartacus Acquisition, a blank check company targeting a TMT business, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The Duluth, GA-based company plans to raise $250 million by offering 25 million units at $10. Each unit consists of

Turmeric Acquisition, a blank check company formed by MPM Capital targeting the biotech industry, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The Cambridge, MA-based company plans to raise $100 million by offering 10 million units

H.I.G. Acquisition, a blank check company formed by H.I.G. Capital, filed on Monday with the SEC to raise up to $450 million in an initial public offering. The Miami, FL-based company plans to raise $450 million by offering 45 million units at $10. Each unit consists of one